David Luebbert, MD
Family Medicine · Columbia, MDNPI 1922419464
Payments from drug & device makers
Across 84 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$328
- Novo Nordisk$257
- Pfizer$253
- Exact Sciences$182
- Merck$152
- Lilly USA, LLC$120
- plus $500 from 16 others
What the payments were for
- Food & beverage$1,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $328 |
| Novo Nordisk | 14 | $257 |
| Pfizer | 15 | $253 |
| Exact Sciences | 8 | $182 |
| Merck | 7 | $152 |
| Lilly USA, LLC | 6 | $120 |
| Bayer | 6 | $107 |
| Johnson & Johnson | 1 | $49 |
| Corcept Therapeutics | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Amgen | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Philips North America LLC | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Tolmar, Inc. | 1 | $14 |
How this compares
$1,792 in reported general payments places this provider in the 75th percentile of 1,193 family medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 32 | $995 |
| Atorvastatin Calcium | 61 | $852 |
| Losartan Potassium | 26 | $432 |
| Tamsulosin Hcl | 21 | $347 |
| Metformin Hcl | 20 | $309 |
| Sildenafil Citrate | 14 | $279 |
| Amlodipine Besylate | 52 | $263 |
| Gabapentin | 15 | $173 |
| Metoprolol Succinate | 18 | $162 |
| Levothyroxine Sodium | 17 | $132 |
| Pravastatin Sodium | 13 | $121 |
| Lisinopril | 27 | $105 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Columbia
- Rajiv DuaColumbia$765K
- Alkesh PatelColumbia$42K
- Njideka UdochiColumbia$12K
- Stephen OngOxon Hill$5.9M
- Stephan BartWoodstock$1.7M
- Karen DonaldsonBaltimore$899K
- Greg TampusLutherville Timonium$735K
- Louis JacquesBaltimore$522K
- Stephanie MellerOxon Hill$518K
- Sharon ChungGlen Burnie$333K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.